A double-blind, randomised placebo-controlled phase I trial to evaluate the safety and immunogenicity of a candidate HIV-1 MVA vaccine, MVA.HIVA, delivered intradermally by a needle injection in healthy HIV-vaccine-na?ve, HIV-uninfected adult Kenyan male and female volunteers
Trial Details:
I
Completed
Kenya AIDS Vaccine Initiative (KAVI), International AIDS Vaccine Initiative (IAVI)